These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Effect of the antibiotic olivomycin on the blood of experimental animals]. VERTOGRADOVA TP Antibiotiki; 1962 Mar; 7():48-53. PubMed ID: 13925588 [No Abstract] [Full Text] [Related]
23. [Evaluation of the specificity of anti-proliferative drugs. Comparison of nitrogen mustard, triethylene melamine and cyclophosphamide]. SCALTRINI GC; TOGNELLA S; CONIGLIARO S; GRIFONI V Haematol Lat; 1961; 4():411-22. PubMed ID: 14497771 [No Abstract] [Full Text] [Related]
24. [Experimental data on an antineoplastic preparation Endoxan]. ASTRAKHAN VI Vopr Onkol; 1962; 8(4)():14-22. PubMed ID: 13863010 [No Abstract] [Full Text] [Related]
25. [Evaluation of the antitumoral properties of a cyclic phosphoramide (Endoxan). Experimental research on the Galliera sarcoma]. DELLEPIANE G; SOCCI M Minerva Ginecol; 1962 May; 14():527-31. PubMed ID: 13885211 [No Abstract] [Full Text] [Related]
26. THE USE OF ENDOXAN IN THE TREATMENT OF CANCER. FICHARDT T; JACOBS EL S Afr Med J; 1964 Sep; 38():740-2. PubMed ID: 14208886 [No Abstract] [Full Text] [Related]
27. EXPERIMENTAL CHEMOTHERAPY STUDIES. V. THE COLLATERAL SENSITIVITY TO ALKYLATING AGENTS OF SEVERAL ANTIMETABOLITE-RESISTANT ASCITES TUMORS IN MICE. RUTMAN RJ Cancer Res; 1964 May; 24():634-8. PubMed ID: 14188466 [No Abstract] [Full Text] [Related]
28. Cyclophosphamide (Cytoxan) in acute leukemia. HOOGSTRATEN B Cancer Chemother Rep; 1962 Feb; 16():167-71. PubMed ID: 13908759 [No Abstract] [Full Text] [Related]
29. INTERACTION BETWEEN 5-HYDROXYTRYPTAMINE AND ANTITUMOURAL DRUGS. PALMA V; REYERS-DEGLIINNOCENTI I; GARATTINI S J Pharm Pharmacol; 1964 Nov; 16():770-1. PubMed ID: 14241150 [No Abstract] [Full Text] [Related]
30. Cyclophosphamide (cytoxan) in acute leukemia, preliminary report. HOOGSTRATEN B Cancer Chemother Rep; 1960 Jul; 8():116-9. PubMed ID: 14402990 [No Abstract] [Full Text] [Related]
31. THE TREATMENT OF CARCINOMA IN DOGS' BLADDERS WITH CYTOTOXIC DRUGS. BOYLAND E; KINDER CH; WILLIAMS K Invest Urol; 1965 Mar; 2():446-52. PubMed ID: 14261785 [No Abstract] [Full Text] [Related]
32. The treatment of mycosis fungoides with a new agent, cyclophosphamide (Cytoxan). ABELE DC; DOBSON RL Arch Dermatol; 1960 Nov; 82():725-31. PubMed ID: 13680984 [No Abstract] [Full Text] [Related]
33. Cyclophosphamide (Cytoxan) therapy of childhood neuroblastoma. Preliminary report. KONTRAS SB; NEWTON WA Cancer Chemother Rep; 1961 Jun; 12():39-50. PubMed ID: 13753021 [No Abstract] [Full Text] [Related]
34. THE ADVERSE EFFECTS OF CANCER CHEMOTHERAPY. KONDO T Acta Unio Int Contra Cancrum; 1964; 20():194-8. PubMed ID: 14151882 [No Abstract] [Full Text] [Related]
35. [THE TOTAL BLOOD ALKYLATING AGENT CONCENTRATION IN RATS AFTER ADMINISTRATION OF CYCLOPHOSPHAMIDE AND ACYCLOPHOSPHAMIDE]. RAUEN HM; KRAMER KP Arzneimittelforschung; 1964 Sep; 14():1066-7. PubMed ID: 14344166 [No Abstract] [Full Text] [Related]
36. [Damage from an antimitotic agent (cyclophosphamide) on juvenile metaphysial cartilage]. GIAMBELLI G Biol Lat; 1961; 14():117-22. PubMed ID: 13898282 [No Abstract] [Full Text] [Related]